Ultrasound to check lymph nodes after head and neck cancer treatment
Part of Cancer clinical trials.
This trial uses contrast-enhanced ultrasound (a special type of ultrasound) to see how well neck lymph nodes respond to chemotherapy and immunotherapy given before surgery for head and neck squamous cell carcinoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of head and neck squamous cell carcinoma
- You received chemotherapy combined with immunotherapy before surgery
- CT or MRI scans before treatment showed cancer in your neck lymph nodes
- You had radical surgery at this hospital that included removal of neck lymph nodes
- You completed the full course of pre-surgery therapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special ultrasound test using “microbubbles” can help doctors find lymph nodes that may contain cancer in people with head and neck squamous cell carcinoma. If the test finds suspicious nodes, it may guide where to do a biopsy during planned neck surgery.
This trial tests a new surgical technique to rebuild the lymphatic system in the neck during surgery for head and neck squamous cell carcinoma. It aims to reduce swelling and improve recovery after cancer removal.
This trial tests a new combination of an immunotherapy drug (adelbelimab) plus chemotherapy given before surgery for head and neck cancer. The goal is to see if this treatment can shrink tumors and improve outcomes for people with advanced but removable head and neck squamous cell carcinoma.
This Phase 2 study tests whether giving low-dose radiation before surgery—along with chemotherapy and an immunotherapy drug—can work better and be safe for treating locally advanced head and neck squamous cell cancer. It may help shrink tumors before surgery and reduce the chance of the cancer coming back.
This early-stage study tests two different imaging (scanning) methods to better detect head and neck cancer. Your results from the scans may help doctors see where disease is before standard surgery to remove lymph nodes in the neck.
This Phase 1 study tests a labelling of panitumumab with iodine (111In) to see how well it can identify lymph nodes in head and neck cancer before surgery. The goal is to improve lymph node staging (which can help guide treatment), with the main focus on safety and early performance.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.